Literature DB >> 22710157

SH3 domain ligand binding: What's the consensus and where's the specificity?

Kalle Saksela1, Perttu Permi.   

Abstract

An increasing number of SH3 domain-ligand interactions continue to be described that involve the conserved peptide-binding surface of SH3, but structurally deviate substantially from canonical docking of consensus motif-containing SH3 ligands. Indeed, it appears that that the relative frequency and importance of these types of interactions may have been underestimated. Instead of atypical, we propose referring to such peptides as type I or II (depending on the binding orientation) non-consensus ligands. Here we discuss the structural basis of non-consensus SH3 ligand binding and the dominant role of the SH3 domain specificity zone in selective target recognition, and review some of the best-characterized examples of such interactions.
Copyright © 2012 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.

Mesh:

Substances:

Year:  2012        PMID: 22710157     DOI: 10.1016/j.febslet.2012.04.042

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  92 in total

1.  CD2-associated protein (CD2AP) overexpression accelerates amyloid precursor protein (APP) transfer from early endosomes to the lysosomal degradation pathway.

Authors:  Kotaro Furusawa; Toshiyuki Takasugi; Yung-Wen Chiu; Yukiko Hori; Taisuke Tomita; Mitsunori Fukuda; Shin-Ichi Hisanaga
Journal:  J Biol Chem       Date:  2019-05-28       Impact factor: 5.157

2.  The SH3 domain of Fyn kinase interacts with and induces liquid-liquid phase separation of the low-complexity domain of hnRNPA2.

Authors:  Joshua Amaya; Veronica H Ryan; Nicolas L Fawzi
Journal:  J Biol Chem       Date:  2018-11-05       Impact factor: 5.157

3.  Crystal structures of human soluble adenylyl cyclase reveal mechanisms of catalysis and of its activation through bicarbonate.

Authors:  Silke Kleinboelting; Ana Diaz; Sebastien Moniot; Joop van den Heuvel; Michael Weyand; Lonny R Levin; Jochen Buck; Clemens Steegborn
Journal:  Proc Natl Acad Sci U S A       Date:  2014-02-24       Impact factor: 11.205

4.  The crystal structure of Klebsiella pneumoniae FeoA reveals a site for protein-protein interactions.

Authors:  Richard O Linkous; Alexandrea E Sestok; Aaron T Smith
Journal:  Proteins       Date:  2019-06-17

5.  Consensus sequence design as a general strategy to create hyperstable, biologically active proteins.

Authors:  Matt Sternke; Katherine W Tripp; Doug Barrick
Journal:  Proc Natl Acad Sci U S A       Date:  2019-05-20       Impact factor: 11.205

6.  A Transformation-Defective Polyomavirus Middle T Antigen with a Novel Defect in PI3 Kinase Signaling.

Authors:  Deborah Denis; Cecile Rouleau; Brian S Schaffhausen
Journal:  J Virol       Date:  2017-01-03       Impact factor: 5.103

7.  The intrinsically disordered linker of E. coli SSB is critical for the release from single-stranded DNA.

Authors:  Hui Yin Tan; Luke A Wilczek; Sasheen Pottinger; Maria Manosas; Cong Yu; Trong Nguyenduc; Piero R Bianco
Journal:  Protein Sci       Date:  2017-03-08       Impact factor: 6.725

8.  Up-regulation of N-cadherin by Collagen I-activated Discoidin Domain Receptor 1 in Pancreatic Cancer Requires the Adaptor Molecule Shc1.

Authors:  Huocong Huang; Robert A Svoboda; Audrey J Lazenby; Jintana Saowapa; Nina Chaika; Ke Ding; Margaret J Wheelock; Keith R Johnson
Journal:  J Biol Chem       Date:  2016-09-07       Impact factor: 5.157

9.  Large-Scale Screening of Preferred Interactions of Human Src Homology-3 (SH3) Domains Using Native Target Proteins as Affinity Ligands.

Authors:  Arunas Kazlauskas; Constanze Schmotz; Tapio Kesti; Jussi Hepojoki; Iivari Kleino; Tomonori Kaneko; Shawn S C Li; Kalle Saksela
Journal:  Mol Cell Proteomics       Date:  2016-07-20       Impact factor: 5.911

10.  SOS1 interacts with Grb2 through regions that induce closed nSH3 conformations.

Authors:  Tsung-Jen Liao; Hyunbum Jang; David Fushman; Ruth Nussinov
Journal:  J Chem Phys       Date:  2020-07-28       Impact factor: 3.488

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.